PMC3586455_01
(A) Discitis and osteomyelitis are seen on this T2-weighted MR image of the lumbar spine which demonstrates infective destruction of the L4-5 disk space with the adjacent L4 and L5 vertebral bodies. (B) T2-weighted MR image of the lumbar spine demonstrates diskitis and osteomyelitis persisting despite 4-week treatment of ceftazidime and vancomycine. (C) Eight weeks after the treatment of teikoplanin. T2-weighted MR image of the lumbar spine demonstrates significant resolution in signs of discitis and osteomyelitis. (D) Nine months after the diagnosis. T2-weighted MR image of the lumbar spine demonstrates no recurrence of discitis or osteomyelitis.
CRIM.ID2013-843592.001.jpg
PMC3586455_01_CRIM.ID2013-843592.001.jpg
fig1
Lumbar MRI scan was done, and lumbar spondylodiscitis was detected (Figure 1(A). In lumbar MRI scan done after 4 weeks of ceftazidime and vancomycine treatment, signs of spondylodiscitis were persisting (Figure 1(B)), and infection markers were still high (erythrocyte sedimentation rate: 60 mm/h, C-reactive protein: 4.8 mg/L, and white blood cells: 9.1 x 109/L). Lumbar MRI scan revealed significant improvement in signs of spondylodiscitis (Figure 1(C)), and antimicrobial treatment was ended. No recurrence of spondylodiscitis was seen in lumbar MRI done nine months after the time of diagnosis (Figure 1(D)).